Cargando…
Scrotal hemorrhage after testicular sperm aspiration may be associated with phosphodiesterase-5 inhibitor administration: a retrospective study
BACKGROUND: Scrotal hemorrhage after testicular sperm aspiration (TESA) is uncommon in clinical operation. Phosphodiesterase-5 inhibitors (PDE5i) are commonly given to men who have difficulty providing a sperm sample for assisted reproductive technique such as in vitro fertilization. In this study,...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802098/ https://www.ncbi.nlm.nih.gov/pubmed/29409493 http://dx.doi.org/10.1186/s12894-018-0316-9 |
_version_ | 1783298475662770176 |
---|---|
author | Zhu, Yong-tong Hua, Rui Quan, Song Tan, Wan-long Chu, Qing-jun Wang, Chun-yan |
author_facet | Zhu, Yong-tong Hua, Rui Quan, Song Tan, Wan-long Chu, Qing-jun Wang, Chun-yan |
author_sort | Zhu, Yong-tong |
collection | PubMed |
description | BACKGROUND: Scrotal hemorrhage after testicular sperm aspiration (TESA) is uncommon in clinical operation. Phosphodiesterase-5 inhibitors (PDE5i) are commonly given to men who have difficulty providing a sperm sample for assisted reproductive technique such as in vitro fertilization. In this study, we examine the incidence of scrotal hemorrhage after TESA in men who received a PDE5i. METHODS: In this retrospective study, 504 men with TESA operation in Center for Reproductive Medicine, Nanfang Hospital, Southern Medical University were collected. Men in the drug group had taken orally PDE5i before TESA. Men in the control group only operated TESA. The testis volume, coagulation function were measured. Sonographic examination with Doppler imaging was performed when scrotal hemorrhage appeared. RESULTS: A total of 504 men with a mean age of 28.63 ± 4.22 years were included in the analysis. Of these, 428 did not receive a PDE5i prior to TESA and 76 received a PDE5i prior to TESA. Measures of coagulation function were not different between the groups. The incidence of hemorrhage was 0.0% in the control group and the drug group was 5.3%. The incidence of hemorrhage between two groups was different significantly (P = 0.000). CONCLUSION: In summary, the results of this study suggest that a PDE5i administration increases the risk of scrotal hemorrhage in men undergoing TESA, although the study design does not allow drawing a conclusion of cause and effect. Given the potential risk of scrotal hemorrhage after the ingestion of PDE5i, it may be wise not to administer it to men in whom a TESA may be performed. |
format | Online Article Text |
id | pubmed-5802098 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58020982018-02-14 Scrotal hemorrhage after testicular sperm aspiration may be associated with phosphodiesterase-5 inhibitor administration: a retrospective study Zhu, Yong-tong Hua, Rui Quan, Song Tan, Wan-long Chu, Qing-jun Wang, Chun-yan BMC Urol Research Article BACKGROUND: Scrotal hemorrhage after testicular sperm aspiration (TESA) is uncommon in clinical operation. Phosphodiesterase-5 inhibitors (PDE5i) are commonly given to men who have difficulty providing a sperm sample for assisted reproductive technique such as in vitro fertilization. In this study, we examine the incidence of scrotal hemorrhage after TESA in men who received a PDE5i. METHODS: In this retrospective study, 504 men with TESA operation in Center for Reproductive Medicine, Nanfang Hospital, Southern Medical University were collected. Men in the drug group had taken orally PDE5i before TESA. Men in the control group only operated TESA. The testis volume, coagulation function were measured. Sonographic examination with Doppler imaging was performed when scrotal hemorrhage appeared. RESULTS: A total of 504 men with a mean age of 28.63 ± 4.22 years were included in the analysis. Of these, 428 did not receive a PDE5i prior to TESA and 76 received a PDE5i prior to TESA. Measures of coagulation function were not different between the groups. The incidence of hemorrhage was 0.0% in the control group and the drug group was 5.3%. The incidence of hemorrhage between two groups was different significantly (P = 0.000). CONCLUSION: In summary, the results of this study suggest that a PDE5i administration increases the risk of scrotal hemorrhage in men undergoing TESA, although the study design does not allow drawing a conclusion of cause and effect. Given the potential risk of scrotal hemorrhage after the ingestion of PDE5i, it may be wise not to administer it to men in whom a TESA may be performed. BioMed Central 2018-02-06 /pmc/articles/PMC5802098/ /pubmed/29409493 http://dx.doi.org/10.1186/s12894-018-0316-9 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Zhu, Yong-tong Hua, Rui Quan, Song Tan, Wan-long Chu, Qing-jun Wang, Chun-yan Scrotal hemorrhage after testicular sperm aspiration may be associated with phosphodiesterase-5 inhibitor administration: a retrospective study |
title | Scrotal hemorrhage after testicular sperm aspiration may be associated with phosphodiesterase-5 inhibitor administration: a retrospective study |
title_full | Scrotal hemorrhage after testicular sperm aspiration may be associated with phosphodiesterase-5 inhibitor administration: a retrospective study |
title_fullStr | Scrotal hemorrhage after testicular sperm aspiration may be associated with phosphodiesterase-5 inhibitor administration: a retrospective study |
title_full_unstemmed | Scrotal hemorrhage after testicular sperm aspiration may be associated with phosphodiesterase-5 inhibitor administration: a retrospective study |
title_short | Scrotal hemorrhage after testicular sperm aspiration may be associated with phosphodiesterase-5 inhibitor administration: a retrospective study |
title_sort | scrotal hemorrhage after testicular sperm aspiration may be associated with phosphodiesterase-5 inhibitor administration: a retrospective study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802098/ https://www.ncbi.nlm.nih.gov/pubmed/29409493 http://dx.doi.org/10.1186/s12894-018-0316-9 |
work_keys_str_mv | AT zhuyongtong scrotalhemorrhageaftertesticularspermaspirationmaybeassociatedwithphosphodiesterase5inhibitoradministrationaretrospectivestudy AT huarui scrotalhemorrhageaftertesticularspermaspirationmaybeassociatedwithphosphodiesterase5inhibitoradministrationaretrospectivestudy AT quansong scrotalhemorrhageaftertesticularspermaspirationmaybeassociatedwithphosphodiesterase5inhibitoradministrationaretrospectivestudy AT tanwanlong scrotalhemorrhageaftertesticularspermaspirationmaybeassociatedwithphosphodiesterase5inhibitoradministrationaretrospectivestudy AT chuqingjun scrotalhemorrhageaftertesticularspermaspirationmaybeassociatedwithphosphodiesterase5inhibitoradministrationaretrospectivestudy AT wangchunyan scrotalhemorrhageaftertesticularspermaspirationmaybeassociatedwithphosphodiesterase5inhibitoradministrationaretrospectivestudy |